Seeing Is Believing
NVCR is currently covered by 9 analysts with an average potential upside of $17.53 (31.18%) from yesterday's end of day stock price of $12.5. NovoCure activity chart has currently 84 price targets and 88 ratings on display.
Analysts average stock forecasts to be materialized ratio is 86.03% with an average time for these price targets to be met of 121 days.
Highest price target for NVCR is $119, Lowest price target is $20, average price target is $69.5.
Most recent stock forecast was given by EMILY BODNAR from HCWAINWRIGHT on 28-Aug-2023. First documented stock forecast 29-Jul-2016.
Currently, out of the existing stock ratings of NVCR - 4 which are a Sell (14.81%), 18 which are a Buy (66.67%), 5 which are a Hold (18.52%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
25
$8.85 (54.80%)
85
3 months 6 days ago
2/5 (40%)
$40.74 (88.94%)
152
Buy
45
$32.5 (260.00%)
62
3 months 26 days ago
14/22 (63.64%)
$32.67 (35.57%)
87
Hold
33
$20.5 (164.00%)
4 months 3 days ago
5/6 (83.33%)
$-15.49 (-14.57%)
128
Buy
95
$82.5 (660.00%)
5 months 28 days ago
2/4 (50%)
$42.96 (70.12%)
115
Hold
50
$33.85 (209.60%)
99
8 months 17 days ago
3/3 (100%)
$-6.7 (-8.42%)
42
What is NVCR (NovoCure) average time for price targets to be met?
Which analyst has the current highest performing score on NVCR (NovoCure) with a proven track record?
Which analyst has the most public recommendations on NVCR (NovoCure)?
Which analyst is the currently most bullish on NVCR (NovoCure)?
Which analyst is the currently most reserved on NVCR (NovoCure)?